Is Hair Loss from Ozempic Permanent
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities (ClinicalTrials.gov Identifier: NCT05051579)
For ongoing monitoring after the acute period, arrange a follow-up appointment with your GP or diabetes specialist nurse within a few days to review your blood glucose control, assess for any delayed complications, and discuss strategies to prevent future dosing errors
If the side effects persist, your health care provider may prescribe a different medication that supports blood sugar control and weight loss
According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025
But many other peptides promoted online have never been approved, making them technically illegal to market as drugs